Research Article

Folic Acid Modified Glucosamine/Methotrexate Polymer Targeted Therapy for Rheumatoid Arthritis

Figure 5

Cytotoxicity of folic acid-glucosamine/methotrexate polymer (FA-Glu/MTX).